Handelsavisen
prelaunch
Companies Basic Materials NRZ.AX
NR
NRZ.AX ASX Chemicals

NeuRizer Ltd

A$0,00
Open in Charts → Attach watcher ⌖
AUD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
3,4M AUD
P/E
EV / Rev
Div yield
Op margin
ROE
-7,7 %
Net margin
Debt / equity
0,03
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

NeuRizer Ltd operates in the Chemicals industry within the Materials sector, though specific revenue-generating activities are not detailed in the available data.

Business. NeuRizer Ltd (NRZ.AX) is a chemicals company listed on the Australian Securities Exchange. The firm operates within the Materials sector, focusing on the production and sale of chemical products. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a participant in the broader chemicals market.

Classification85 %
SectorMaterials
Industry groupChemicals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-7,7 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning NRZ.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to NRZ.AX. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    NeuRizer Ltd (NRZ.AX) is a chemicals company listed on the Australian Securities Exchange. The firm operates within the Materials sector, focusing on the production and sale of chemical products. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a participant in the broader chemicals market.

    Classification85 %
    SectorMaterials
    Industry groupChemicals
    AI synthesis
    GENERATED

    NeuRizer Ltd exhibits a capital structure characterized by minimal leverage but severe liquidity constraints. The company holds total assets of AUD 129.3 million against total liabilities of AUD 56.3 million, resulting in total equity of AUD 73.0 million. Long-term debt is negligible at AUD 2.1 million, yielding a debt-to-equity ratio of 0.03. However, the balance sheet shows zero cash and equivalents, and the current ratio stands at 0.01, indicating an inability to cover short-term obligations with current assets. The market capitalization is AUD 3.4 million, trading at a price-to-book ratio of 0.05, suggesting the market values the firm at a significant discount to its tangible book value.

    Profitability metrics are deeply negative, reflecting a pre-revenue or early-stage loss-making profile. The company reports an operating income of -AUD 2.6 million and a net income of -AUD 5.6 million. Return on equity is -7.67%, and return on assets is -4.33%. These figures indicate that the company is consuming capital rather than generating returns, with no positive earnings to support valuation multiples such as P/E or EV/EBITDA, the latter of which is negative at -2.11.

    Key takeaways
    • The company trades at a 95% discount to book value (P/B 0.05) with a market cap of AUD 3.4 million.
    • Liquidity is critically constrained with a current ratio of 0.01 and zero cash on hand.
    • The firm is unprofitable with a net loss of AUD 5.6 million and negative operating cash flow of AUD 3.6 million.
    • Leverage is minimal with a debt-to-equity ratio of 0.03, but the lack of cash poses immediate operational risks.
    • No historical growth data or segment breakdowns are available to assess business model viability.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2023-10-02
    FY 2023 · Full-year highlights

    Operating income −1,2% YoY; Net income +20,3% YoY.

    Revenue
    Operating income-A$12.6M−1,2 % YoY
    Net income-A$16.3M+20,3 % YoY
    Free cash flow-A$41.5M−56,7 % YoY
    EPS
    Operating cash flow-A$9.0M+11,6 % YoY
    Financials
    Income statement
    Revenue
    Gross profit
    Operating income-A$12.6M
    Net income-A$16.3M
    Balance sheet
    Total assetsA$128.7M
    Total liabilitiesA$55.9M
    Total equityA$72.8M
    Cash & equivalentsA$0.00
    Long-term debtA$2.4M
    Cash flow
    Operating cash flow-A$9.0M
    CapEx-A$25.3M
    Free cash flow-A$41.5M
    SBC
    Highlights
    • Operating income −1,2% YoY
    • Net income +20,3% YoY
    • Free cash flow −56,7% YoY

    Valuation FY

    Market price
    A$0,00
    Market cap
    A$3.4M
    Enterprise value
    A$5.5M
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    0.1x
    P / Tangible book
    0.1x
    Tangible book
    A$73.0M
    Net cash
    -A$2.1M
    Current ratio
    0.0
    Debt / equity
    0.0
    ROA
    -4.3%
    ROE
    -7.7%
    Cash conversion
    64.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    ROE-7,7 %Bottom quartile
    D/E0,03Above median
    Cash Conv0,64Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Enterprise Value
      market_cap - net_cash
    • Return On Equity
      net_income / total_equity
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    Source documents
    • NeuRizer Ltd Market data — financials · 2026-07-14

    Ownership & reference

    Leadership

    • Daniel Justyn Douglas PetersExecutive Chairman of the Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    NRZ.AXCanonical
    ASX · AUD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2023-10-02 02:52 UTCEARNINGSAnnual results — FY 2023 Net AUD -16.3M
    2022-09-30 14:08 UTCEARNINGSAnnual results — FY 2022 Net AUD -20.4M
    2020-08-28 10:52 UTCEARNINGSAnnual results — FY 2020 Net AUD -7.2M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage